DSGN
Price
$4.03
Change
+$0.03 (+0.75%)
Updated
Jun 6, 04:15 PM (EDT)
Capitalization
227.07M
66 days until earnings call
TRDA
Price
$8.36
Change
+$0.24 (+2.96%)
Updated
Jun 6, 04:42 PM (EDT)
Capitalization
307.42M
61 days until earnings call
Interact to see
Advertisement

DSGN vs TRDA

Header iconDSGN vs TRDA Comparison
Open Charts DSGN vs TRDABanner chart's image
Design Therapeutics
Price$4.03
Change+$0.03 (+0.75%)
Volume$600
Capitalization227.07M
Entrada Therapeutics
Price$8.36
Change+$0.24 (+2.96%)
Volume$206
Capitalization307.42M
DSGN vs TRDA Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. TRDA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DSGN: $4.00 vs. TRDA: $8.10)
Brand notoriety: DSGN and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 50% vs. TRDA: 68%
Market capitalization -- DSGN: $227.07M vs. TRDA: $307.42M
DSGN [@Biotechnology] is valued at $227.07M. TRDA’s [@Biotechnology] market capitalization is $307.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -0.25% price change this week, while TRDA (@Biotechnology) price change was +2.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 11, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($307M) has a higher market cap than DSGN($227M). DSGN YTD gains are higher at: -35.170 vs. TRDA (-53.152). TRDA has higher annual earnings (EBITDA): 7.89M vs. DSGN (-67.79M). TRDA has more cash in the bank: 383M vs. DSGN (230M). DSGN has less debt than TRDA: DSGN (2.14M) vs TRDA (57M). TRDA has higher revenues than DSGN: TRDA (172M) vs DSGN (0).
DSGNTRDADSGN / TRDA
Capitalization227M307M74%
EBITDA-67.79M7.89M-859%
Gain YTD-35.170-53.15266%
P/E RatioN/A13.97-
Revenue0172M-
Total Cash230M383M60%
Total Debt2.14M57M4%
TECHNICAL ANALYSIS
Technical Analysis
DSGNTRDA
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
86%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSTSX69.56N/A
N/A
BlackRock Technology Opportunities Svc
TCVAX22.24N/A
N/A
Touchstone Mid Cap Value A
TSMOX14.43N/A
N/A
Nuveen Quant Small/Mid Cap Eq Retirement
HSMFX11.45N/A
N/A
Hartford Small Cap Value F
FAPKX12.61N/A
N/A
Fidelity Advisor Healthy Future C

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-2.44%
VRDN - DSGN
49%
Loosely correlated
+0.60%
KRYS - DSGN
45%
Loosely correlated
+0.53%
IDYA - DSGN
45%
Loosely correlated
-0.09%
AURA - DSGN
44%
Loosely correlated
-0.57%
TRDA - DSGN
43%
Loosely correlated
+2.14%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+2.14%
CRNX - TRDA
56%
Loosely correlated
+0.59%
ATXS - TRDA
53%
Loosely correlated
-1.14%
IMNM - TRDA
53%
Loosely correlated
+1.16%
XERS - TRDA
52%
Loosely correlated
+0.68%
RXRX - TRDA
52%
Loosely correlated
-7.13%
More